McNamara M J, Alexander H R, Norton J A
Surgical Metabolism Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
JPEN J Parenter Enteral Nutr. 1992 Nov-Dec;16(6 Suppl):50S-55S. doi: 10.1177/014860719201600603.
Cancer cachexia describes a syndrome that consists of weight loss, and abnormalities in carbohydrate, protein, and lipid metabolism, which result in a state of persistent net negative energy balance. Patients suffering from cancer cachexia have a significantly shortened survival after cancer treatment. Recent experimental studies have focused on the belief that the mechanisms of cancer cachexia involve the host's production of inflammatory cytokines, which through broad physiologic actions ultimately lead to a chronic state of wasting, malnourishment, and death. Cytokines that have been thought to play a role in the pathophysiology of cachexia include tumor necrosis factor, interleukin-1, interleukin-6, interferon-gamma and differentiation factor. It has become clear that these cytokines have overlapping physiologic activities, which makes it likely that no single substance is the sole cause of cachexia in most cancer patients. Only further investigation may make it possible to more clearly define the role of cytokines in the pathophysiology of cancer cachexia. Specific strategies to reverse the cachectic effects of these substances may then be developed to ultimately improve cancer treatment.
癌症恶病质描述的是一种综合征,其包括体重减轻以及碳水化合物、蛋白质和脂质代谢异常,这些会导致持续的净负能量平衡状态。患有癌症恶病质的患者在癌症治疗后的生存期会显著缩短。最近的实验研究集中在这样一种观点上,即癌症恶病质的机制涉及宿主产生的炎性细胞因子,这些细胞因子通过广泛的生理作用最终导致慢性消瘦、营养不良和死亡状态。被认为在恶病质病理生理学中起作用的细胞因子包括肿瘤坏死因子、白细胞介素-1、白细胞介素-6、干扰素-γ和分化因子。已经清楚的是,这些细胞因子具有重叠的生理活性,这使得在大多数癌症患者中可能没有单一物质是恶病质的唯一原因。只有进一步的研究才可能更清楚地界定细胞因子在癌症恶病质病理生理学中的作用。然后可以制定出逆转这些物质恶病质效应的具体策略,以最终改善癌症治疗。